Since c-Myc up-regulation is tightly associated with deranged metabolism in many cancer types including GBM [20, 21], targeting Btk may provide another venue for restoring normal metabolic function in GBM cells and increase their response towards chemotherapeutic agents. Here, MYC is linked to glioblastoma.